Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

1.74

Today's Change

+0.05 (2.95%)

Day's Change

1.67 - 1.74

Trading Volume

2,233,579

Overview

Market Cap

628 Million

Shares Outstanding

361 Million

Avg Volume

2,828,357

Avg Price (50 Days)

1.67

Avg Price (200 Days)

1.89

PE Ratio

-2.23

EPS

-0.78

Earnings Announcement

06-Nov-2024

Previous Close

1.69

Open

1.69

Day's Range

1.67 - 1.74

Year Range

0.92 - 3.73

Trading Volume

2,237,895

Price Change Highlight

1 Day Change

2.96%

5 Day Change

6.75%

1 Month Change

2.96%

3 Month Change

-6.45%

6 Month Change

-14.29%

Ytd Change

9.43%

1 Year Change

62.62%

3 Year Change

-69.74%

5 Year Change

-47.27%

10 Year Change

-78.39%

Max Change

-98.67%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment